RA Capital Management - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$26,689,000
+4.1%
1,119,9630.0%0.52%
-35.8%
Q1 2020$25,647,000
-19.1%
1,119,9630.0%0.81%
-15.8%
Q4 2019$31,717,000
+31.8%
1,119,9630.0%0.96%
-32.9%
Q3 2019$24,068,000
-26.3%
1,119,9630.0%1.43%
-18.2%
Q2 2019$32,669,0001,119,9631.75%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Skorpios Trust 14,443,681$56,908,10399.78%
Lynx1 Capital Management LP 1,710,154$6,738,0074.46%
COWEN AND COMPANY, LLC 3,721,659$14,663,3361.03%
Redmile Group, LLC 3,872,696$15,258,4220.73%
RTW INVESTMENTS, LP 4,390,558$17,298,7990.36%
Birchview Capital, LP 85,000$334,9000.28%
Cormorant Asset Management, LP 1,087,807$4,285,9600.25%
Granahan Investment Management 851,201$3,353,7320.12%
GSA CAPITAL PARTNERS LLP 348,069$1,3710.12%
Simplify Asset Management Inc. 102,985$405,7610.05%
View complete list of STOKE THERAPEUTICS INC shareholders